New chronic kidney disease review

Complete the eight sections; the KDIGO G-stage, albuminuria stage, risk zone, and review completeness are computed on submit. This is a documentation and classification instrument — there is no numeric score.

  1. Context
  2. Patient
  3. Renal
  4. Albuminuria
  5. Blood pressure
  6. Medication
  7. Bloods
  8. Summary
Step 1 of 8 — Review context

Who is reviewing, when, where, and the review type.

Step 2 of 8 — Patient and diagnosis

Identifier, demographics, diabetes status, and CKD cause.

Diabetes tightens the blood-pressure target to 130/80.

Step 3 of 8 — Renal function (eGFR)

Current eGFR sets the G-stage; the prior value drives the rapid-decline check.

G1 ≥ 90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, G5 < 15.

Used for the rapid-decline check (≥ 25% fall with a G-stage change, or ≥ 15/year).

Step 4 of 8 — Albuminuria (urine ACR)

Urine ACR sets the A-stage; a missing ACR raises a flag and blocks full KDIGO staging.

A1 < 3, A2 3–30, A3 > 30. ACR ≥ 70 raises a referral flag.

No raises a missing-ACR flag.

Step 5 of 8 — Blood pressure

Best of repeated seated readings (mmHg). Target is 130/80 with diabetes or ACR ≥ 70, else 140/90.

Step 6 of 8 — Medication review

RAAS blockade, SGLT2 inhibitor, statin, and the nephrotoxin check.

e.g. NSAID or a renally-cleared agent.

A present nephrotoxin not adjusted raises a high-priority flag.

Step 7 of 8 — Metabolic bloods

Potassium, haemoglobin, and CKD-MBD markers. Potassium and haemoglobin are the core bundle bloods.

≥ 6.0 raises a high-priority hyperkalaemia flag; 5.5–5.9 medium.

< 110 raises an anaemia-of-CKD flag.

Step 8 of 8 — Referral and summary

Live KDIGO classification and review completeness, plus the referral decision and a clinician note.

G-stage Not staged A-stage Not staged
KDIGO zone Not classified (target 140/90; no blood pressure recorded)
Review Incomplete (0 of 5 bundle items; 2 flags)